Towards a 'systems'-level understanding of the nervous system and its disorders

Trends in Neurosciences

Volumn 36, Issue 11, 2013, Pages 674-684

  Qureshi, Irfan A ^a   Mehler, Mark F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine; Enterotype; Hypothalamic neurogenesis; Immune surveillance; Immunoglobulin superfamily; Inflammatory reflex; Leptin; Microbiome; Microvesicle; Neural stem cell; Niche; Tolerance

Indexed keywords

AGOUTI RELATED PROTEIN; BEZAFIBRATE; CELL ADHESION MOLECULE; CHEMOKINE; CIGLITAZONE; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; CYTOKINE; EXENDIN 4; GHRELIN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN SENSITIZING AGENT; LEPTIN; LIRAGLUTIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; PIOGLITAZONE; PROOPIOMELANOCORTIN; PROTEIN; PROTOGENIN; SIRTUIN; TOLL LIKE RECEPTOR 3; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ARCUATE NUCLEUS; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BIOENERGY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CELL VACUOLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHOROID PLEXUS; COMORBIDITY; DEGENERATIVE DISEASE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; EXOSOME; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; INNERVATION; INTESTINE FLORA; MENTAL DISEASE; METABOLIC DISORDER; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; STRESS;

CYTOKINE; ENTEROTYPE; HYPOTHALAMIC NEUROGENESIS; IMMUNE SURVEILLANCE; IMMUNOGLOBULIN SUPERFAMILY; INFLAMMATORY REFLEX; LEPTIN; MICROBIOME; MICROVESICLE; NEURAL STEM CELL; NICHE; TOLERANCE;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; NEURONS;

EID: 84886945841     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.07.003     Document Type: Review

References (117)

1. El Khoury J. Neurodegeneration and the neuroimmune system. Nat. Med. 2010, 16:1369-1370.
2. Drexhage R.C., et al. Immune and neuroimmune alterations in mood disorders and schizophrenia. Int. Rev. Neurobiol. 2011, 101:169-201.
3. Kapogiannis D., Mattson M.P. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 2011, 10:187-198.
4. Rafalski V.A., Brunet A. Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 2011, 93:182-203.
5. Farooqui A.A., et al. Metabolic syndrome as a risk factor for neurological disorders. Cell. Mol. Life Sci. 2012, 69:741-762.
6. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12:453-466.
7. Ochoa-Reparaz J., et al. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann. Neurol. 2011, 69:240-247.
8. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13:701-712.
9. Goddard C.A., et al. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6828-6833.
10. Datwani A., et al. Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron 2009, 64:463-470.
11. Sawcer S., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
12. Baranzini S.E., et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 2009, 18:767-778.
13. Rioux J.D., et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18680-18685.
14. Khankhanian P., et al. Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset. BMC Genomics 2010, 11:626.
15. McElroy J.P., et al. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun. 2011, 12:523-530.
16. + regulatory T cells via a TGF-beta-dependent mechanism. J. Leukoc. Biol. 2009, 86:1275-1283.
17. Katayama Y., et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
18. Mendez-Ferrer S., et al. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
19. Mendez-Ferrer S., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
20. Mercier F.E., et al. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 2011, 12:49-60.
21. Ferraro F., et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci. Transl. Med. 2011, 3:104ra101.
22. Rosas-Ballina M., et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011, 334:98-101.
23. Wong C.H., et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334:101-105.
24. Romo-Gonzalez T., et al. Central nervous system: a modified immune surveillance circuit?. Brain Behav. Immun. 2012, 26:823-829.
25. Trotta M.B., et al. Inflammatory and immunological parameters in adults with Down syndrome. Immun. Ageing 2011, 8:4.
26. von Budingen H.C., et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J. Clin. Invest. 2012, 122:4533-4543.
27. Black J.A., Waxman S.G. Sodium channels and microglial function. Exp. Neurol. 2012, 234:302-315.
28. Odoardi F., et al. T cells become licensed in the lung to enter the central nervous system. Nature 2012, 488:675-679.
29. Zhao P., et al. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 2007, 27:2357-2368.
30. Zhao P., et al. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 2007, 27:8893-8902.
31. Derecki N.C., et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
32. Guerreiro R., et al. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 2012, 368:117-127.
33. Jonsson T., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2012, 368:107-116.
34. Saab C.Y., et al. Alarm or curse? The pain of neuroinflammation. Brain Res. Rev. 2008, 58:226-235.
35. London A., et al. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 2011, 208:23-39.
36. Shechter R., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
37. Garg S.K., et al. IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes. J. Neurochem. 2009, 108:1155-1166.
38. Garg S.K., et al. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J. Immunol. 2008, 180:3866-3873.
39. Kwan W., et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J. Clin. Invest. 2012, 122:4737-4747.
40. Lima F.A., et al. Decreased AIRE expression and global thymic hypofunction in Down syndrome. J. Immunol. 2011, 187:3422-3430.
41. Wekerle H. Breaking ignorance: the case of the brain. Curr. Top. Microbiol. Immunol. 2006, 305:25-50.
42. Turnbaugh P.J., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
43. Turnbaugh P.J., et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1:6ra14.
44. Nikolajczyk B.S., et al. The outliers become a stampede as immunometabolism reaches a tipping point. Immunol. Rev. 2012, 249:253-275.
45. Faulconbridge L.F., Hayes M.R. Regulation of energy balance and body weight by the brain: a distributed system prone to disruption. Psychiatr. Clin. North Am. 2011, 34:733-745.
46. Mistlberger R.E. Neurobiology of food anticipatory circadian rhythms. Physiol. Behav. 2011, 104:535-545.
47. Lam T.K., et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 2005, 11:320-327.
48. Lam T.K., et al. Hypothalamic sensing of fatty acids. Nat. Neurosci. 2005, 8:579-584.
49. Pocai A., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005, 434:1026-1031.
50. He W., et al. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat. Neurosci. 2006, 9:227-233.
51. Kitamura T., et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 2006, 12:534-540.
52. Buettner C., et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat. Med. 2008, 14:667-675.
53. Kokorovic A., et al. Hypothalamic sensing of circulating lactate regulates glucose production. J. Cell. Mol. Med. 2009, 13:4403-4408.
54. Ross R.A., et al. Differential effects of hypothalamic long-chain fatty acid infusions on suppression of hepatic glucose production. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E633-E639.
55. Knight C.M., et al. Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 2011, 60:2691-2700.
56. Ono H., et al. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J. Clin. Invest. 2008, 118:2959-2968.
57. Lin H.V., et al. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 2010, 59:337-346.
58. Xu Y., et al. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver. Nat. Neurosci. 2010, 13:1457-1459.
59. Hill J.W., et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 2010, 11:286-297.
60. Muse E.D., et al. Hypothalamic resistin induces hepatic insulin resistance. J. Clin. Invest. 2007, 117:1670-1678.
61. Dietrich M.O., Horvath T.L. Hypothalamic control of energy balance: insights into the role of synaptic plasticity. Trends Neurosci. 2013, 36:65-73.
62. Bouret S.G., et al. Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. J. Neurosci. 2012, 32:1244-1252.
63. Varela L., Horvath T.L. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 2012, 13:1079-1086.
64. Steculorum S.M., Bouret S.G. Maternal diabetes compromises the organization of hypothalamic feeding circuits and impairs leptin sensitivity in offspring. Endocrinology 2011, 152:4171-4179.
65. Bouyer K., Simerly R.B. Neonatal leptin exposure specifies innervation of presympathetic hypothalamic neurons and improves the metabolic status of leptin-deficient mice. J. Neurosci. 2013, 33:840-851.
66. Pinto S., et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004, 304:110-115.
67. Yang Y., et al. Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell 2011, 146:992-1003.
68. Kokoeva M.V., et al. Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science 2005, 310:679-683.
69. Garza J.C., et al. Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J. Biol. Chem. 2008, 283:18238-18247.
70. Moon M., et al. Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr. J. 2009, 56:525-531.
71. McNay D.E., et al. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J. Clin. Invest. 2012, 122:142-152.
72. Cowley M.A., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
73. Bouret S.G. Neurodevelopmental actions of leptin. Brain Res. 2010, 1350:2-9.
74. Maiese K., et al. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol. Med. 2013, 19:51-60.
75. O'Neill C., et al. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem. Soc. Trans. 2012, 40:721-727.
76. Amato S., Man H.Y. Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases. Cell Cycle 2011, 10:3452-3460.
77. Donmez G. The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol. Sci. 2012, 33:494-501.
78. Thaler J.P., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122:153-162.
79. Pierce A.A., Xu A.W. De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance. J. Neurosci. 2010, 30:723-730.
80. Czupryn A., et al. Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice. Science 2011, 334:1133-1137.
81. Matarese G., et al. Leptin as a metabolic link to multiple sclerosis. Nat. Rev. Neurol. 2010, 6:455-461.
82. + T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J. Immunol. 2010, 185:7474-7479.
83. Olsson B., et al. Biomarker-based dissection of neurodegenerative diseases. Prog. Neurobiol. 2011, 95:520-534.
84. Pinto M., et al. Regional susceptibilities to mitochondrial dysfunctions in the CNS. Biol. Chem. 2012, 393:275-281.
85. Vetter M.L., et al. Behavioral and pharmacologic therapies for obesity. Nat. Rev. Endocrinol. 2010, 6:578-588.
86. Clemente J.C., et al. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
87. Round J.L., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
88. Heijtz R.D., et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3047-3052.
89. Clarke G., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 2012, 18:666-673.
90. Bravo J.A., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16050-16055.
91. Finegold S.M., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16:444-453.
92. Pollinger B., et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 2009, 206:1303-1316.
93. Berer K., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
94. Ochoa-Reparaz J., et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010, 3:487-495.
95. Ochoa-Reparaz J., et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. 2010, 185:4101-4108.
96. O'Mahony S.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 2009, 65:263-267.
97. Bailey M.T., et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 2011, 25:397-407.
98. Wu G.D., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
99. Davey K.J., et al. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl.) 2012, 221:155-169.
100. Iyengar R., et al. Merging systems biology with pharmacodynamics. Sci. Transl. Med. 2012, 4:126ps127.
101. Goldman S.A., Chen Z. Perivascular instruction of cell genesis and fate in the adult brain. Nat. Neurosci. 2011, 14:1382-1389.
102. Lucas D., et al. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 2008, 3:364-366.
103. Skog J., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
104. Mustafa A.K., et al. Signaling by gasotransmitters. Sci. Signal. 2009, 2:re2.
105. Moriyama M., et al. Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J. Neurosci. 2011, 31:3981-3989.
106. Stevens B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
107. Blank M., et al. The Down syndrome critical region regulates retinogeniculate refinement. J. Neurosci. 2011, 31:5764-5776.
108. Wong Y.H., et al. Protogenin defines a transition stage during embryonic neurogenesis and prevents precocious neuronal differentiation. J. Neurosci. 2010, 30:4428-4439.
109. Fathi A., et al. Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells. PLoS ONE 2011, 6:e22856.
110. Okun E., et al. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15625-15630.
111. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
112. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
113. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 2012, 7:42-59.
114. Hardie D.G., et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
115. Ghasemi R., et al. Insulin in the brain: sources, localization and functions. Mol. Neurobiol. 2013, 47:145-171.
116. Coppari R. Metabolic actions of hypothalamic SIRT1. Trends Endocrinol. Metab. 2012, 23:179-185.
117. Zhang F., et al. Protective effects and mechanisms of sirtuins in the nervous system. Prog. Neurobiol. 2011, 95:373-395.